Concurrent Transcranial Direct Current Stimulation and Gait Training in Parkinson's Disease

Sponsor
National Yang Ming University (Other)
Overall Status
Unknown status
CT.gov ID
NCT04041661
Collaborator
(none)
30
2
13

Study Details

Study Description

Brief Summary

To investigate the effect of concurrent transcranial direct current stimulation and gait training on gait performance when doing the cognitive dual-task in people with Parkinson's Disease.

Condition or Disease Intervention/Treatment Phase
  • Other: Active tDCS plus gait training
  • Other: Sham tDCS plus gait training
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effect of Concurrent Transcranial Direct Current Stimulation and Gait Training on Gait Performance When Doing the Cognitive Dual-task in People With Parkinson's Disease
Anticipated Study Start Date :
Aug 1, 2019
Anticipated Primary Completion Date :
Aug 31, 2020
Anticipated Study Completion Date :
Aug 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Active tDCS plus gait training group

Participants in Active tDCS plus gait training group will execute Active tDCS on left dorsolateral prefrontal cortex which combined with treadmill, 12 times per week, least 4 weeks.

Other: Active tDCS plus gait training
Participants in experimental group will accept Active tDCS which combined with treadmill

Sham Comparator: Sham tDCS plus gait training group

Participants in Sham tDCS plus gait training group will executeSham tDCS on left dorsolateral prefrontal cortex which combined with treadmill, 12 times per week, least 4 weeks.

Other: Sham tDCS plus gait training
Participants in control group will accept Sham tDCS which combined with treadmill

Outcome Measures

Primary Outcome Measures

  1. Dual-task walking performance [Change from baseline at 4 weeks]

    To evaluate gait parameters while doing dual-task walking

Secondary Outcome Measures

  1. Single walking performance [Change from baseline at 4 weeks]

    To evaluate gait parameters while doing single walking

  2. Trail-making test A & B [Change from baseline at 4 weeks]

    To evaluate executive function

  3. Stroop color and word test-Chinese version [Change from baseline at 4 weeks]

    To evaluate executive function

  4. Digit span test [Change from baseline at 4 weeks]

    To evaluate executive function

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosed with idiopathic PD

  • Hoehn and Yahr stages I-III

  • Mini Mental Status Examination (MMSE) score ≧ 24

  • Could walk 10m independently with or without gait aid

Exclusion Criteria:
  • Concurrent medication likely to affect mental performance

  • tDCS contraindication

  • Significant neurological, vestibular, visual disorders or psychiatric illness

  • Musculoskeletal or cardiopulmonary disease

  • Sensory system pathology

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • National Yang Ming University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yea-Ru Yang, Professor, National Yang Ming University
ClinicalTrials.gov Identifier:
NCT04041661
Other Study ID Numbers:
  • 19MMHIS113e
First Posted:
Aug 1, 2019
Last Update Posted:
Aug 6, 2019
Last Verified:
Aug 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yea-Ru Yang, Professor, National Yang Ming University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 6, 2019